Suppr超能文献

Design and synthesis of novel hybrid benzamide-peptide histone deacetylase inhibitors.

作者信息

Hu Fang, Chou C James, Gottesfeld Joel M

机构信息

Department of Molecular Biology, The Scripps Research Institute, La Jolla, CA 92037, USA.

出版信息

Bioorg Med Chem Lett. 2009 Jul 15;19(14):3928-31. doi: 10.1016/j.bmcl.2009.03.085. Epub 2009 Mar 25.

Abstract

We designed and synthesized a series of novel hybrid histone deacetylase inhibitors based on conjugation of benzamide-type inhibitors with either linear or cyclic peptides. Linear tetrapeptides (compounds 13 and 14), cyclic tetrapeptides (compounds 1 and 11), and heptanediamide-peptide conjugates (compounds 10, 12, 15 and 16) were synthesized through on-resin solid-phase peptide synthesis (SPPS). All compounds were found to be moderate HDAC1 and HDAC3 inhibitors, with IC(50) values ranging from 1.3 microM to 532 microM. Interestingly, compound 15 showed 19-fold selectivity for HDAC3 versus HDAC1.

摘要

相似文献

1
Design and synthesis of novel hybrid benzamide-peptide histone deacetylase inhibitors.
Bioorg Med Chem Lett. 2009 Jul 15;19(14):3928-31. doi: 10.1016/j.bmcl.2009.03.085. Epub 2009 Mar 25.
5
Design, synthesis and docking studies on benzamide derivatives as histone deacetylase inhibitors.
Bioorg Med Chem Lett. 2011 Aug 15;21(16):4924-7. doi: 10.1016/j.bmcl.2011.06.001. Epub 2011 Jun 16.
7
Identification of novel isoform-selective inhibitors within class I histone deacetylases.
J Pharmacol Exp Ther. 2003 Nov;307(2):720-8. doi: 10.1124/jpet.103.055541. Epub 2003 Sep 15.
8
Synthesis and histone deacetylase inhibitory activity of new benzamide derivatives.
J Med Chem. 1999 Jul 29;42(15):3001-3. doi: 10.1021/jm980565u.
9
Stereoselective HDAC inhibition from cysteine-derived zinc-binding groups.
ChemMedChem. 2009 Aug;4(8):1292-301. doi: 10.1002/cmdc.200900088.

引用本文的文献

1
Peptide-Based 2-Aminophenylamide Probes for Targeting Endogenous Class I Histone Deacetylase Complexes.
Chembiochem. 2019 Dec 13;20(24):3001-3005. doi: 10.1002/cbic.201900339. Epub 2019 Sep 26.
2
The Process and Strategy for Developing Selective Histone Deacetylase 3 Inhibitors.
Molecules. 2018 Mar 2;23(3):551. doi: 10.3390/molecules23030551.
4
Vorinostat-like molecules as structural, stereochemical, and pharmacological tools.
ACS Med Chem Lett. 2010 Mar 11;1(2):70-4. doi: 10.1021/ml100028g. eCollection 2010 May 13.
5
Retinoic acid and histone deacetylases regulate epigenetic changes in embryonic stem cells.
J Biol Chem. 2014 Jul 11;289(28):19519-30. doi: 10.1074/jbc.M114.556555. Epub 2014 May 12.
7
Control of HIV latency by epigenetic and non-epigenetic mechanisms.
Curr HIV Res. 2011 Dec 1;9(8):554-67. doi: 10.2174/157016211798998736.
8
Comprehensive survey of chemical libraries for drug discovery and chemical biology: 2009.
J Comb Chem. 2010 Nov 8;12(6):765-806. doi: 10.1021/cc100128w. Epub 2010 Oct 5.

本文引用的文献

1
Pimelic diphenylamide 106 is a slow, tight-binding inhibitor of class I histone deacetylases.
J Biol Chem. 2008 Dec 19;283(51):35402-9. doi: 10.1074/jbc.M807045200. Epub 2008 Oct 24.
2
The HDAC inhibitor 4b ameliorates the disease phenotype and transcriptional abnormalities in Huntington's disease transgenic mice.
Proc Natl Acad Sci U S A. 2008 Oct 7;105(40):15564-9. doi: 10.1073/pnas.0804249105. Epub 2008 Sep 30.
3
Therapeutic role of sirtuins in neurodegenerative disease.
Biochim Biophys Acta. 2008 Jun;1782(6):363-9. doi: 10.1016/j.bbadis.2008.02.010. Epub 2008 Mar 7.
4
NAD+-dependent deacetylation of H4 lysine 16 by class III HDACs.
Oncogene. 2007 Aug 13;26(37):5505-20. doi: 10.1038/sj.onc.1210617.
5
Histone deacetylases--an important class of cellular regulators with a variety of functions.
Appl Microbiol Biotechnol. 2007 Jun;75(3):487-97. doi: 10.1007/s00253-007-0911-2. Epub 2007 Mar 22.
7
Histone deacetylase inhibitors reverse gene silencing in Friedreich's ataxia.
Nat Chem Biol. 2006 Oct;2(10):551-8. doi: 10.1038/nchembio815. Epub 2006 Aug 20.
8
Crystal structure of a eukaryotic zinc-dependent histone deacetylase, human HDAC8, complexed with a hydroxamic acid inhibitor.
Proc Natl Acad Sci U S A. 2004 Oct 19;101(42):15064-9. doi: 10.1073/pnas.0404603101. Epub 2004 Oct 11.
10
Histone deacetylase inhibitors in cancer therapy: is transcription the primary target?
Cancer Cell. 2003 Jul;4(1):13-8. doi: 10.1016/s1535-6108(03)00165-x.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验